Globus Medical, Inc. (GMED) Balance Sheet
GMED balance sheet, 2025
December 31, 2025 · U.S. dollars$5.30B assets = $729.5M liabilities + $4.57B equity
Both columns are drawn to the same scale: what GMED owns equals what it owes plus shareholders’ equity. Hover a block for its value.
GMED financial health
Descriptive bands, not a rating. Fiscal 2025.
GMED balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $927.6M2016 | $5.30B2025 | +21.4%/yr | |
| Total liabilities | $95.6M2016 | $729.5M2025 | +25.3%/yr | |
| Shareholders’ equity | $832.1M2016 | $4.57B2025 | +20.8%/yr | |
| Cash & short-term investments | $290.3M2016 | $557.2M2025 | +7.5%/yr | |
| Total debt | $4.5M2018 | $118.7M2025 | +59.5%/yr | |
| Net cash (debt) | $335.2M2018 | $438.6M2025 | +$103.4M | |
| Working capital | $433.9M2016 | $1.63B2025 | +$1.2B | |
| Book value per share | $8.632016 | $33.332025 | +16.2%/yr | |
| Current ratio | 6.432016 | 4.262025 | −2.17 | |
| Debt / equity | 0.002018 | 0.032025 | +0.02 | |
| Shares outstanding | 96.4M2016 | 137.2M2025 | +4.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
GMED assets
GMED liabilities and equity
GMED debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
GMED balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $557.2M | $890.1M | $517.8M | $446.1M | $443.4M | $426.7M | $311.5M | $339.7M | $373.7M | $290.3M |
| Cash & equivalents | $526.2M | $784.4M | $467.3M | $150.5M | $193.1M | $239.4M | $195.7M | $139.7M | $118.8M | $67.0M |
| Short-term investments | $31.1M | $105.6M | $50.5M | $295.6M | $250.4M | $187.3M | $115.8M | $199.9M | $254.9M | $223.4M |
| Receivables | $743.7M | $578.3M | $504.9M | $217.3M | $165.7M | $148.1M | $162.4M | $144.4M | $127.1M | $95.8M |
| Inventory | $759.3M | $659.2M | $848.1M | $299.0M | $237.0M | $229.2M | $196.3M | $131.3M | $108.4M | $112.7M |
| Other current assets | $65.4M | $49.6M | $44.6M | $21.0M | $18.4M | $17.8M | $17.2M | $15.4M | $11.2M | $15.0M |
| Total current assets | $2.13B | $2.18B | $1.92B | $983.3M | $864.5M | $821.8M | $687.5M | $630.7M | $620.3M | $513.8M |
| Property, plant & equipment (net) | $628.2M | $611.6M | $646.9M | $243.7M | $221.1M | $216.9M | $199.8M | $171.9M | $143.2M | $124.2M |
| Goodwill & intangible assets | $2.18B | $2.23B | $2.36B | $261.0M | $248.4M | $243.7M | $207.6M | $211.1M | $202.5M | $167.6M |
| Long-term investments | $71.8M | $66.1M | $75.4M | $495.9M | $562.5M | $358.5M | $409.5M | $263.1M | $56.1M | $60.4M |
| Other non-current assets | $297.0M | $169.3M | $89.3M | $92.2M | $60.8M | $38.7M | $27.7M | $23.9M | $56.3M | $61.6M |
| Total assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $927.6M |
| Liabilities | ||||||||||
| Accounts payable | $98.9M | $75.1M | $56.7M | $36.1M | $22.0M | $18.2M | $24.6M | $25.9M | $25.0M | $17.5M |
| Short-term debt | $14.7M | $453.6M | $12.0M | $2.5M | $94.4M | $88.7M | $74.7M | $4.5M | — | — |
| Deferred revenue | $27.7M | $22.1M | $18.4M | $14.1M | $12.0M | $8.1M | $5.4M | $2.6M | $755,000 | — |
| Total current liabilities | $498.5M | $855.9M | $392.3M | $159.2M | $140.2M | $120.8M | $111.4M | $96.1M | $93.1M | $79.9M |
| Long-term debt | $0 | $0 | $417.4M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $118.7M | $93.8M | $103.0M | $6.0M | — | — | — | — | — | — |
| Other long-term liabilities | $231.0M | $218.5M | $278.4M | $70.5M | $75.7M | $52.4M | $18.2M | $19.0M | $17.7M | $15.7M |
| Total liabilities | $729.5M | $1.07B | $1.09B | $229.8M | $215.9M | $173.2M | $129.6M | $115.2M | $110.7M | $95.6M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $135,000 | $137,000 | $136,000 | $100,000 | $101,000 | $99,000 | $99,000 | $98,000 | $97,000 | $96,000 |
| Retained earnings (deficit) | $1.39B | $1.15B | $1.14B | $1.24B | $1.19B | $1.05B | $1.05B | $892.7M | $736.2M | $628.9M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | $15.3M | −$6.9M | −$10.2M | −$24.6M | −$6.8M | $4.0M | −$2.9M | −$7.2M | −$6.9M | −$8.6M |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B | $1.51B | $1.40B | $1.19B | $967.8M | $832.1M |
| Key figures | ||||||||||
| Total debt | $118.7M | $537.2M | $520.4M | $6.0M | $5.1M | $4.8M | $2.5M | $4.5M | — | — |
| Net cash (debt) | $438.6M | $352.9M | −$2.6M | $440.0M | $438.4M | $421.9M | $309.0M | $335.2M | — | — |
| Working capital | $1.63B | $1.32B | $1.52B | $824.1M | $724.4M | $701.0M | $576.1M | $534.6M | $527.3M | $433.9M |
| Tangible book value | $2.39B | $1.95B | $1.64B | $1.59B | $1.49B | $1.26B | $1.19B | $974.5M | $765.2M | $664.4M |
| Book value per share | $33.33 | $30.30 | $34.88 | $17.99 | $16.81 | $14.92 | $13.75 | $11.70 | $9.89 | $8.63 |
| Shares outstanding | 137.2M | 137.9M | 114.6M | 102.6M | 103.6M | 101.0M | 102.0M | 101.3M | 97.9M | 96.4M |
| Current ratio | 4.26 | 2.54 | 4.88 | 6.18 | 6.17 | 6.80 | 6.17 | 6.56 | 6.67 | 6.43 |
| Quick ratio | 2.61 | 1.72 | 2.61 | 4.17 | 4.35 | 4.76 | 4.25 | 5.04 | 5.38 | 4.83 |
| Debt / equity | 0.03 | 0.13 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| Equity / assets | 86.2% | 79.5% | 78.6% | 88.9% | 89.0% | 89.7% | 91.5% | 91.1% | 89.7% | 89.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $595.1M | $629.9M | $557.2M | $390.5M | $229.4M | $461.3M | $890.1M | $694.7M | $492.9M | $434.5M | $517.8M | $468.9M |
| Cash & equivalents | $507.7M | $561.0M | $526.2M | $371.8M | $229.4M | $461.3M | $784.4M | $622.8M | $410.4M | $354.1M | $467.3M | $279.6M |
| Short-term investments | $87.4M | $68.9M | $31.1M | $18.8M | $0 | $0 | $105.6M | $71.9M | $82.5M | $80.4M | $50.5M | $189.3M |
| Receivables | $739.3M | $735.4M | $743.7M | $688.1M | $660.1M | $538.1M | $578.3M | $593.2M | $614.3M | $534.7M | $504.9M | $495.9M |
| Inventory | $810.9M | $772.6M | $759.3M | $771.5M | $772.1M | $663.6M | $659.2M | $717.7M | $770.5M | $816.2M | $848.1M | $905.0M |
| Other current assets | $70.2M | $60.2M | $65.4M | $74.2M | $68.2M | $47.1M | $49.6M | $50.9M | $46.2M | $43.2M | $44.6M | $47.6M |
| Total current assets | $2.22B | $2.20B | $2.13B | $1.92B | $1.73B | $1.71B | $2.18B | $2.06B | $1.92B | $1.83B | $1.92B | $1.92B |
| Property, plant & equipment (net) | $592.7M | $618.6M | $628.2M | $637.2M | $649.1M | $604.9M | $611.6M | $620.6M | $627.3M | $635.9M | $646.9M | $701.7M |
| Goodwill & intangible assets | $2.13B | $2.16B | $2.18B | $2.21B | $2.23B | $2.20B | $2.23B | $2.27B | $2.32B | $2.34B | $2.36B | $2.38B |
| Long-term investments | $245.4M | $169.4M | $71.8M | $16.7M | $0 | $0 | $66.1M | $12.3M | $27.8M | $51.3M | $75.4M | $276.0M |
| Other non-current assets | $303.9M | $293.8M | $297.0M | $309.2M | $350.7M | $191.5M | $169.3M | $122.1M | $94.1M | $88.6M | $89.3M | $76.8M |
| Total assets | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | $5.09B | $5.36B |
| Liabilities | ||||||||||||
| Accounts payable | $106.9M | $103.7M | $98.9M | $87.2M | $87.1M | $73.1M | $75.1M | $57.5M | $67.2M | $50.5M | $56.7M | $86.9M |
| Short-term debt | $14.4M | $15.1M | $14.7M | $14.4M | $13.2M | $10.6M | $453.6M | $448.2M | $441.6M | $435.8M | $12.0M | $13.4M |
| Deferred revenue | $28.0M | $26.3M | $27.7M | $18.3M | $24.0M | $17.2M | $22.1M | $20.8M | $19.8M | $17.1M | $18.4M | $18.0M |
| Total current liabilities | $479.3M | $482.5M | $498.5M | $466.0M | $424.7M | $384.7M | $855.9M | $818.1M | $794.1M | $786.3M | $392.3M | $428.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $417.4M | $409.7M |
| Lease obligations | $111.2M | $115.2M | $118.7M | $119.3M | $121.1M | $92.3M | $93.8M | $97.4M | $98.8M | $101.6M | $103.0M | $113.3M |
| Other long-term liabilities | $240.3M | $224.8M | $231.0M | $230.9M | $240.7M | $238.4M | $218.5M | $198.6M | $223.3M | $234.9M | $278.4M | $330.1M |
| Total liabilities | $719.7M | $707.2M | $729.5M | $696.8M | $665.4M | $623.1M | $1.07B | $1.02B | $1.02B | $1.02B | $1.09B | $1.17B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $134,000 | $135,000 | $135,000 | $134,000 | $135,000 | $135,000 | $137,000 | $135,000 | $135,000 | $135,000 | $136,000 | $140,000 |
| Retained earnings (deficit) | $1.53B | $1.51B | $1.39B | $1.29B | $1.21B | $1.04B | $1.15B | $1.13B | $1.07B | $1.05B | $1.14B | $1.35B |
| Accumulated other comprehensive income | $11.2M | $14.4M | $15.3M | $10.9M | $10.2M | −$2.2M | −$6.9M | −$7.0M | −$11.9M | −$11.0M | −$10.2M | −$18.7M |
| Total shareholders' equity | $4.77B | $4.73B | $4.57B | $4.40B | $4.30B | $4.09B | $4.18B | $4.07B | $3.98B | $3.92B | $4.00B | $4.19B |
| Key figures | ||||||||||||
| Total debt | $111.2M | $115.2M | $118.7M | $119.3M | $121.1M | $92.3M | $537.2M | $534.6M | $529.3M | $525.6M | $520.4M | $523.0M |
| Net cash (debt) | $483.9M | $514.6M | $438.6M | $271.2M | $108.3M | $369.0M | $352.9M | $160.1M | −$36.4M | −$91.1M | −$2.6M | −$54.1M |
| Working capital | $1.74B | $1.72B | $1.63B | $1.46B | $1.31B | $1.33B | $1.32B | $1.24B | $1.13B | $1.04B | $1.52B | $1.49B |
| Tangible book value | $2.64B | $2.57B | $2.39B | $2.19B | $2.06B | $1.88B | $1.95B | $1.79B | $1.66B | $1.58B | $1.64B | $1.80B |
| Book value per share | $34.51 | $34.24 | $33.33 | $32.49 | $31.47 | $29.25 | $29.90 | $29.48 | $29.03 | $28.98 | $28.76 | $36.33 |
| Shares outstanding | 138.2M | 138.2M | 137.2M | 135.4M | 136.5M | 139.8M | 139.7M | 138.1M | 137.0M | 135.4M | 139.0M | 115.2M |
| Current ratio | 4.62 | 4.56 | 4.26 | 4.13 | 4.07 | 4.45 | 2.54 | 2.51 | 2.42 | 2.33 | 4.88 | 4.47 |
| Quick ratio | 2.78 | 2.83 | 2.61 | 2.31 | 2.09 | 2.60 | 1.72 | 1.57 | 1.39 | 1.23 | 2.61 | 2.25 |
| Debt / equity | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.12 |
| Equity / assets | 86.9% | 87.0% | 86.2% | 86.3% | 86.6% | 86.8% | 79.5% | 80.0% | 79.6% | 79.3% | 78.6% | 78.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 24, 2026); data from EODHD.
GMED financial position
At the end of fiscal 2025 (December 31, 2025), Globus Medical had total assets of $5.3 billion (up 1.0% from a year earlier), total liabilities of $729.5 million and shareholders' equity of $4.6 billion. It held $557.2 million in cash and short-term investments against $118.7 million of debt, a net cash position of $438.6 million. Its current ratio was 4.26. In the latest quarter (ended June 30, 2026) total assets were $5.5 billion and equity $4.8 billion.
Related: GMED income statement, GMED cash flow statement, GMED key metrics. See the GMED stock overview for the latest quote and news.
GMED balance sheet FAQ
What are Globus Medical's total assets?
Globus Medical reported total assets of $5.3 billion at the end of fiscal 2025 (December 31, 2025), compared with $5.3 billion a year earlier.
How much debt does Globus Medical have?
Globus Medical had $118.7 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.03.
How much cash does Globus Medical have?
Globus Medical held $557.2 million in cash and short-term investments at the end of fiscal 2025; with $118.7 million of debt that is net cash of $438.6 million.
What is Globus Medical's book value?
Globus Medical's shareholders' equity (book value) was $4.6 billion at the end of fiscal 2025, or $33.33 per share.
What is Globus Medical's current ratio?
Globus Medical had current assets of $2.1 billion and current liabilities of $498.5 million, a current ratio of 4.26 (it can cover its short-term obligations).
How much goodwill does Globus Medical have?
Globus Medical carried $2.2 billion of goodwill and intangible assets, 41.1% of total assets, at the end of fiscal 2025.